Financials in USD. Standardized financial statements.
A compact view of how Envoy Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue? | $241,000 | $225,000 | $316,000 | $237,000 | $310,000 | $0 |
| Revenue Growth? | +7.1% | -28.8% | +33.3% | -23.5% | 0.0% | 0.0% |
| Cost of Revenue? | $874,000 | $742,000 | $789,000 | $498,000 | $769,000 | $0 |
| Gross Profit? | -$633,000 | -$517,000 | -$473,000 | -$261,000 | -$459,000 | $0 |
| Gross Margin? | -262.7% | -229.8% | -149.7% | -110.1% | -148.1% | 0.0% |
| Operating Expenses? | $21.64M | $18.74M | $17.89M | $8.45M | $6.41M | $701 |
| Operating Income? | -$22.27M | -$19.26M | -$18.36M | -$8.71M | -$6.87M | -$701 |
| EBITDA? | -$21.97M | -$19.81M | -$29.79M | -$8.63M | -$6.80M | -$701 |
| Income Before Tax | -$23.76M | -$20.80M | -$29.92M | -$15.92M | -$8.68M | -$701 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$23.76M | -$20.80M | -$29.92M | -$15.92M | -$8.68M | -$701 |
| EPS? | $-1.23 | $-1.49 | $-2.54 | $-1.57 | $-1.05 | $0.00 |
| Diluted EPS? | $-1.23 | $-1.49 | $-2.54 | $-1.57 | $-1.05 | $0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality